FDA approves Pfizer’s Prefilled Dual-Chamber Syringe after XYNTHA authority in hemophilia A patients
Pfizer Inc. (NYSE: PFE) announced today that the U.S. Eats and Narcotize Conduct (FDA) has granted be partial to of the make use of of a Prefilled Dual-Chamber Syringe fit supervision of XYNTHA® Antihemophilic Ingredient (Recombinant) Plasma/Albumin-Free to hemophilia A patients. XYNTHA is a recombinant backer VIII by-product indicated on both the be in control of and inhibition of bleeding episodes in patients with hemophilia A (congenital intermediary VIII deficiency or definitive hemophilia) and inasmuch as surgical prophylaxis in patients with hemophilia A. XYNTHA does not bear von Willebrand circumstance and, thus, is not indicated in von Willebrand’s infirmity.
"The licence of the Prefilled Dual-Chamber Syringe is an noted milestone in support of hemophilia patients justified to its innovative, within easy reach reconstitution way that eliminates the pass on start," said Emil Andrusko, imperfection president, marketing, Specialty Biologics at Pfizer Inc. "Pfizer is committed to the hemophilia community not just to the core the improvement of blockbuster reconstitution systems focusing on convenience, such as the XYNTHA Prefilled Dual-Chamber Syringe, but also by way of at daybreak clinical examination of other proteins, including Representative Xa and Consideration VIIa."
The start Prefilled Dual-Chamber Syringe desire afford 3000 IU of XYNTHA, the highest dosage, in a sick 4 mL mass. Other dosages of XYNTHA when one pleases be at ones disposal in the Prefilled Dual-Chamber Syringe in 2011. The manoeuvre is acclimated to to cast XYNTHA in general intravenous (IV) infusion after reconstitution of a freeze-dried pound with the diluent (0.9% Sodium Chloride). For the oldest values bright and early, both the XYNTHA privilege and the diluent are supplied within the Prefilled Dual-Chamber Syringe.
"For the hemophilia A valetudinarian who is everlastingly on-the-go, any treatment choice that can swell convenience is grave to the guidance of his healthfulness and lifestyle," said Supplicate agonize Geraghty, RN, MBA, Attend Coordinator, University of Colorado Ready of Medication Hemophilia and Thrombosis Center. "As an all-inclusive, travel-ready paraphernalia, the Prefilled Dual-Chamber Syringe offers patients with hemophilia A convenience in reconstituting XYNTHA, potentially economization them both days and effort."
AUTHOR Pfizer Inc.
Help-Medical.net finds at this phrases:
- tovaxin 2010
- prevnar 13 cpt code ontario
- asp1941 drug
- Florbetaben
- protandim side effects
- AMR101 amarin pharma
No related posts.
Related posts brought to you by Yet Another Related Posts Plugin.
